Medicine and Dentistry
Inflammatory Bowel Disease
87%
Ulcerative Colitis
85%
Crohn's Disease
66%
Patient with Inflammatory Bowel Disease
54%
Colorectal Cancer
38%
Disease
34%
Chromoendoscopy
34%
Dysplasia
33%
Neoplasm
27%
Surgery
23%
Biopsy
21%
Colectomy
19%
Colitis
19%
Severe Acute Respiratory Syndrome Coronavirus 2
17%
Symptom
17%
Colonoscopy
16%
Combination Therapy
15%
Systematic Review with Meta-Analysis
15%
Recurrent Disease
15%
Drug Therapy
15%
Tertiary Care
10%
Cohort Analysis
10%
COVID-19 Vaccination
10%
Anal Fistula
10%
Biological Therapy
9%
Ustekinumab
9%
Colon Mucosa
9%
Endoscopy
9%
Disease Management
9%
Odds Ratio
9%
Meta-Analysis
8%
Colorectal Tumor
7%
Granulomatous Colitis
7%
Next Generation Sequencing
7%
Tumor Necrosis Factor Antibody
7%
Lung Nodule
7%
Antibody Therapy
7%
Intestine Surgery
7%
Autoimmune Disease
7%
Whole Genome Sequencing
7%
Ileostomy
7%
Antibody Response
7%
Precursor
7%
Infection
7%
Epstein Barr Virus
7%
Ipilimumab
7%
Surgery for Inflammatory Bowel Disease
7%
Prospective Study
7%
Interleukin 6
7%
Adalimumab
7%
Keyphrases
Inflammatory Bowel Disease
100%
Crohn's Disease
63%
Ulcerative Colitis
33%
SARS-CoV-2 mRNA Vaccination
22%
Colorectal Cancer
21%
Neoplasia
19%
Remission
16%
Dysplasia
16%
Colonoscopy
15%
Perianal Crohn's Disease
15%
Histological Remission
15%
Serrated Epithelial Change
15%
Case-controlled Study
15%
Clinical Outcome Prediction
15%
Systematic Meta-analysis
15%
Post-vaccination Symptoms
15%
Crohn's Disease Recurrence
15%
Virtual Chromoendoscopy
14%
Colectomy
14%
Disease Location
14%
Inflammation
12%
Endoscopic Recurrence
11%
Anti-tumor Necrosis Factor (anti-TNF)
10%
Perianal Fistula
10%
Disease-associated
10%
Ustekinumab
10%
Paddington
9%
Colon Resection
9%
Rutgeerts Score
9%
Colonic mucosa
9%
Interleukin-6
9%
High-grade Dysplasia
9%
Crohn's
9%
Mucosal Healing
9%
Biologic Therapy
9%
Mucosa-associated Microbiota
9%
Histological Score
8%
Colitis-associated Dysplasia
8%
Ulcerative Colitis Patient
8%
Meta-analysis
8%
Colitis
8%
Clinical Outcomes
8%
Endoscopic Remission
8%
2-dose
8%
Endoscopic Diagnosis
8%
Histological Assessment
7%
In Situ Hybridization
7%
Refractory Course
7%
Artificial Intelligence Systems
7%
Managerial Roles
7%
Immunology and Microbiology
Inflammatory Bowel Disease
63%
Crohn's Disease
34%
Colitis
20%
Colon Mucosa
17%
Severe Acute Respiratory Syndrome Coronavirus 2
15%
Mouse
15%
Vaccination Policy
15%
Colon
12%
Ulcerative Colitis
12%
Titer
9%
Ileum
9%
Genetic Variation
8%
Bacteroides fragilis
7%
Epstein Barr Virus
7%
Ipilimumab
7%
Haplotype
7%
Whole Genome Sequencing
7%
Dendritic Cell
7%
NLRP3 Inflammasome
7%
Adaptive Immune System
7%
Antibody Response
7%
CXCR3
7%
Pancreatitis
7%
Interleukin 6
7%
in Situ Hybridization
7%
Genetic Code
7%
Phagocytosis
7%
Systemic Inflammation
7%
Complement Factor B
7%
Mosaicism
7%
Microflora
7%
Ileum Mucosa
7%
Vaccine Efficacy
6%